Allogeneic stem cell transplantation in elderly patients with acute myeloid leukemia

DOI Web Site PubMed
  • KOBAYASHI Sumiko
    Tokyo Metropolitan Gerontology Hospital and Institute of Gerontology, Hematology/Transfusion and Cell Therapy

Bibliographic Information

Other Title
  • 高齢者AMLにおける造血細胞移植療法
  • コウレイシャ AML ニ オケル ゾウケツ サイボウ イショク リョウホウ

Search this article

Abstract

<p>Acute myeloid leukemia is a disease that mainly affects older populations, with a median age at diagnosis of 67 years, and outcomes for these patients are poor. Reduced-intensity regimen improves survival after allogeneic hematopoietic cell transplantation (HCT), but this has not been well studied. To reduce non-relapse mortality (NRM) among the elderly, geriatric assessment, HCT-Comorbidity index, and disease risk must be studied before HCT.</p>

Journal

  • Rinsho Ketsueki

    Rinsho Ketsueki 60 (9), 1120-1130, 2019

    The Japanese Society of Hematology

Keywords

Details 詳細情報について

Report a problem

Back to top